Clinical Trials Logo

Temporomandibular Disorder clinical trials

View clinical trials related to Temporomandibular Disorder.

Filter by:

NCT ID: NCT03975920 Completed - Clinical trials for Temporomandibular Disorder

Assessing a New Jaw Support Device During Third Molar Extractions

Start date: June 25, 2019
Phase: N/A
Study type: Interventional

During mandibular 3rd molar (wisdom tooth) extractions, when a downward force is placed on the patient's jaw, the patient must tense his/her jaw muscles to oppose it. Patients under moderate/deep sedation or general anesthesia cannot tense their muscles to counter this downward force to prevent injury to the jaw including the temporomandibular joint (TMJ). Bite blocks hold the patient's mouth open but do not counter this downward force on the mandible. Currently, oral and maxillofacial surgeons (OMSs) when surgically removing 3rd molars (wisdom teeth) with moderate/deep sedation or general anesthesia have a dental assistant that stands behind the chair and places their hands on both sides of the jaw to support it and oppose the downward force on the patient's jaw during the extractions. It is hard for the dental assistant to maintain support while anticipating the direction and amount of force placed by the OMS on the patient's jaw during the surgical removal. This may explain the finding that almost a quarter of new onset TMD cases in young adults is associated with 3rd molar removal. This study will look at the use of a jaw support device to provide a stable counterforce to downward forces on the jaw, thus preventing jaw hyperextension and injury to the jaw.

NCT ID: NCT03891121 Completed - Clinical trials for Temporomandibular Disorder

Occlusal Splints or Botulinum Toxin?

Start date: April 5, 2018
Phase: N/A
Study type: Interventional

73 patients with myofascial pain due to bruxism were included in this study. The patient were allocated into three groups. Group A was treated with occlusal splint, Group B was treated with botulinum toxin injection, Group C was treated with occlusal splint and botulinum toxin injection together. Temporomandibular Disorder Pain Screener (TMD-PS), Graded Chronic Pain Scale (GCPS), Oral Behavior Checklist (OBC), Jaw Function Limitation Scale (JFLS), Visual Analog Scale (VAS) by palpation of the chewing muscles were administered to all patients before treatment and at 6 months after treatment.

NCT ID: NCT03849534 Recruiting - Clinical trials for Temporomandibular Disorder

Treatment of Temporomandibular Disorders in Children and Adolsecents

TMD/PED
Start date: September 1, 2023
Phase: N/A
Study type: Interventional

Children and adolescents are treated with routine treatment approaches for adults and one of the most commonly used treatments are occlusal appliances. The use of occlusal appliances in managing orofacial pain conditions is supported by evidence, but only for adults. However, the efficacy of the treatment approaches and any possible side-effects/impairment of mandibular growth are absent. Therefore, the aim of this project is to investigate the effectiveness and possible side-effects of different treatment modalities, such as an occlusal appliance, jaw exercises, NSAID for the conditions myalgia orarthralgia in the orofacial region in children with primary or mixed dentition.

NCT ID: NCT03844971 Recruiting - Clinical trials for Temporomandibular Disorder

Computer Guided Arthrocentesis of Temporomandibular

Start date: January 12, 2019
Phase: N/A
Study type: Interventional

Computer guided arthrocentesis of temporomandibular joint for patients with anterior disc displacement with reduction using patient specific guide

NCT ID: NCT03844412 Completed - Clinical trials for Irritable Bowel Syndrome

Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments

Start date: November 4, 2019
Phase: Phase 2
Study type: Interventional

Vestibulodynia (VBD) is a complex chronic vulvar pain condition that impairs the psychological, physical, and sexual health of 1 in 6 reproductive aged women in the United States. Here, the investigators plan to conduct a randomized, double-blinded, placebo-controlled clinical trial to 1) compare the efficacy of peripheral (lidocaine/estradiol cream), centrally-targeted (nortriptyline), and combined treatments in alleviating pain and improving patient-reported outcomes and 2) determine cytokine and microRNA biomarkers that predict treatment response in women with distinct VBD subtypes. Positive findings from this study will readily translate to improved patient care, permitting the millions of women with VBD, their partners, and their clinicians to make more informed decisions about pain management.

NCT ID: NCT03726060 Completed - Clinical trials for Temporomandibular Disorder

Effectiveness of Physical Teraphy in the Treatment of Myogenic Temporomandibular Disorders

Start date: October 31, 2018
Phase: N/A
Study type: Interventional

The aim of study is evaluate the effectiveness of physical therapy in of the treatment myogenic temporomandibular disorders. They will enrolled 100 patient which will be divided into two groups. The primary objective is evaluate the effectiveness of physiotherapy on pain (measured with the Visual Analogic Scale - VAS scale). The second objective is evaluate mandibular motion (by measuring the range of motion - ROM) and investigate the presence of psychosocial factors (using the Anxiety and Depression Scale - HADS questionnaire).

NCT ID: NCT03724032 Terminated - Clinical trials for Temporomandibular Disorder

Investigation and Modulation of the Mu-opioid Mechanisms in TMD (in Vivo)

Start date: December 13, 2018
Phase: N/A
Study type: Interventional

In this study, this team of researchers will investigate the impact of chronic temporomandibular disorder suffering on the endogenous μ-opioid system in vivo, arguably one of the principal endogenous pain modulatory systems in the brain, and its modulation by 10 daily sessions of primary motor cortex stimulation using high-definition transcranial direct current stimulation (HD-tDCS).

NCT ID: NCT03696706 Recruiting - Clinical trials for Temporomandibular Disorder

Photobiomodulation With Red and Infrared LED Device for Temporomandibular Dysfunction

Start date: October 15, 2018
Phase: Phase 2
Study type: Interventional

Temporomandibular Dysfunction - TMD is considered the main cause of orofacial pain of non-dental origin, and a public health problem. Due to their complexity there are already treatments using various forms of therapy. Photobiomodulation using different light sources, in a single or combined form, makes it possible to use it as another therapeutic resource to be explored. The objective of this study will be to evaluate the effects of photobiomodulation with simultaneous use of light emitting diodes (LEDs), red and infrared, on clinical aspects in individuals with TMD. A randomized, controlled and blind clinical trial is proposed, which will involve 33 individuals (n = 11 per group) of both genders, aged 18-45 years in three groups: Group 1 - LED; Group 2 - placebo and Group 3 - control, submitted to 6 nonconsecutive sessions of photobiomodulation totaling 2 weeks of treatment. The Research Diagnostic Criteria for Temporomandibular Disorders - RDC/TMD will be used to determine the TMD and evaluate the participants. Pain will be assessed using the visual analog scale (VAS), mandibular range of motion will be determined with the aid of a digital caliper, and the electrical activity of the masticatory muscles will be verified by electromyography. A mixed plate of 18 red LEDs - 660 nm and 18 infrared LEDs - 850 nm with power of 3.5 mW per LED, 4.45 mW/cm2, radiant exposure of 5,35 J/cm2, irradiated area of 14.13 cm2, and energy of 75.6 J, in the temporomandibular joint (TMJ) region and in the masseter and temporal muscles, bilateral in 6 sessions. Participants from all groups will be reassessed after the first therapeutic intervention, and again at the end, following the same evaluation procedures used initially.

NCT ID: NCT03619889 Completed - Clinical trials for Temporomandibular Disorder

The Effectiveness of a Physiotherapy Technique in Patients With Chronic Myofascial Temporomandibular Disorder

TrP-TMD
Start date: October 2015
Phase: N/A
Study type: Interventional

Participants with chronic orofacial pain caused by masticatory and neck muscles will be distributed in two groups, both followed with the same occlusal and self-care treatment. The experimental group will receive 5 sessions of physiotherapy applying a specific pressure on the trigger points while the control group will receive placebo through a simulation of the same technique. Orofacial perceived pain, pain pressure thresholds, catastrophizing, kinesiophobia, cervical disability, depression and anxiety will be evaluated at baseline, immediately after treatment and 3 months later.

NCT ID: NCT03556150 Completed - Clinical trials for Temporomandibular Disorder

Effectiveness of a Manual Therapy Protocol in Patients With Masticatory Muscle Disorders

Start date: June 15, 2018
Phase: N/A
Study type: Interventional

Comparing the efficiency between manual therapy protocol and effleurage in patients with temporomandibular disorders.